Literature DB >> 11143245

Gamma knife radiosurgery for pituitary adenomas.

M Izawa1, M Hayashi, K Nakaya, H Satoh, T Ochiai, T Hori, K Takakura.   

Abstract

OBJECT: The purpose of this study was the analysis of a large series of patients treated with gamma knife radiosurgery for pituitary adenoma in a single institution.
METHODS: One hundred eight patients with pituitary adenomas were treated over the last 7 years. Seventy-four patients have been followed for more than 6 months and form the basis of this report.
CONCLUSIONS: Twenty-three patients harbored nonfunctioning adenomas, and 56 harbored functioning adenomas. The mean margin dose was 22.5 Gy (nonfunctioning adenomas, 19.5 Gy; functioning adenomas, 23.8 Gy). Control of tumor growth was achieved in 91%. A significant decrease of excessive hormone production was seen in 80% of patients, and the endocrinological normalization rate was 30.3%. Postradiosurgical complications were seen in 2.5%.

Entities:  

Mesh:

Year:  2000        PMID: 11143245     DOI: 10.3171/jns.2000.93.supplement

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  33 in total

Review 1.  Radiation therapy in acromegaly.

Authors:  Helen A Shih; Jay S Loeffler
Journal:  Rev Endocr Metab Disord       Date:  2008-03       Impact factor: 6.514

Review 2.  Radiotherapy and radiosurgery in acromegaly.

Authors:  Frédéric Castinetti; Isabelle Morange; Henry Dufour; Jean Regis; Thierry Brue
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

Review 3.  Treatment paradigms for pituitary adenomas: defining the roles of radiosurgery and radiation therapy.

Authors:  Dale Ding; Robert M Starke; Jason P Sheehan
Journal:  J Neurooncol       Date:  2014-05       Impact factor: 4.130

Review 4.  Updates in outcomes of stereotactic radiation therapy in acromegaly.

Authors:  Monica Livia Gheorghiu
Journal:  Pituitary       Date:  2017-02       Impact factor: 4.107

Review 5.  Target delineation and optimal radiosurgical dose for pituitary tumors.

Authors:  Giuseppe Minniti; Mattia Falchetto Osti; Maximillian Niyazi
Journal:  Radiat Oncol       Date:  2016-10-11       Impact factor: 3.481

Review 6.  The Treatment of Cushing's Disease.

Authors:  Rosario Pivonello; Monica De Leo; Alessia Cozzolino; Annamaria Colao
Journal:  Endocr Rev       Date:  2015-06-11       Impact factor: 19.871

7.  Repeat endoscopic transsphenoidal surgery for acromegaly: remission and complications.

Authors:  Thomas J Wilson; Erin L McKean; Ariel L Barkan; William F Chandler; Stephen E Sullivan
Journal:  Pituitary       Date:  2013-12       Impact factor: 4.107

8.  A single-institution restrospective experience of brachytherapy in the treatment of pituitary tumors: transsphenoidal approach combined with (192)Ir-afterloading catheters.

Authors:  A Di Mambro; C Giuliani; F Ammannati; E Mannucci; S Scoccianti; B Detti; I Meattini; P Mennonna; G Forti; M Serio; A Peri
Journal:  J Endocrinol Invest       Date:  2009-12-01       Impact factor: 4.256

Review 9.  Radiotherapy of nonfunctioning and gonadotroph adenomas.

Authors:  Andrew A Kanner; Benjamin W Corn; Yona Greenman
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

10.  Radiosurgery for pituitary adenomas: evaluation of its efficacy and safety.

Authors:  Douglas G Castro; Soraya A J Cecílio; Miguel M Canteras
Journal:  Radiat Oncol       Date:  2010-11-17       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.